期 |
栏目 |
标题 |
文件 |
卷 15, 编号 1 (2013) |
Articles |
Efficacy and safety of pemetrexed maintenance therapy in advanced non-small-cell lung cancer: a review of phase III studies |
|
卷 16, 编号 1 (2014) |
Articles |
The Avastin application in clinical practice in patients with metastatic colorectal cancer: Second interim analysis of the observational AJAX program |
|
卷 21, 编号 2 (2019) |
Articles |
The potential of using eribulin in patients with breast cancer, associated with brain metastasis: the scientific background and the Russian clinical experience |
(Rus)
|
卷 21, 编号 1 (2019) |
Articles |
Efficacy and safety of eribulin in HER2-negative metastatic breast cancer: the results of long-term experience in real clinical practice in Russia |
(Rus)
|
卷 21, 编号 4 (2019) |
CLINICAL ONCOLOGY |
The role of a multidisciplinary approach in the treatment of hepatocellular carcinoma |
(Rus)
|
卷 23, 编号 1 (2021) |
CLINICAL ONCOLOGY |
Analysis of the efficacy and safety of eribulin therapy in patients with HR+/HER2- metastatic breast cancer pretreated with CDK4/6 inhibitors in real Russian practice |
(Rus)
(Eng)
|
卷 23, 编号 1 (2021) |
CLINICAL ONCOLOGY |
Prognostic role of clinical and biological factors and parameters of hormonal profile in patients with primary inoperable HER2-negative breast cancer |
(Rus)
|
卷 23, 编号 3 (2021) |
CLINICAL ONCOLOGY |
Malignant neoplasm of the bronchi and lung: Russian clinical guidelines |
(Rus)
|
卷 24, 编号 3 (2022) |
CLINICAL ONCOLOGY |
Malignant neoplasm of the bronchi and lung: Russian clinical guidelines |
(Rus)
|
卷 26, 编号 1 (2024) |
Articles |
Safety and efficacy of ribociclib in combination with letrozole in an extended population of patients with HR+/HER2- advanced breast cancer: analysis of data from a subgroup of patients from Russia in the phase lllb CompLEEment-1 study |
(Rus)
|